4 November 2021PatentsAlex Baldwin

Hirshfeld grants first USPTO director review after Arthrex

The acting director of the US Patent and Trademark Office Drew Hirshfeld has agreed for the first time to review a final written decision from the Patent Trial and Appeal Board (PTAB) after being given oversight over the board’s rulings in the Supreme Court’s Arthrex decision.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Influential Women in IP

'Sluggish' growth in women inventor numbers: USPTO

13 February 2019 Women inventors still make up just 12% of all patent inventors in the US, according to the US Patent and Trademark Office.

Patents

Hirshfeld defends IPR review authority under Arthrex

3 February 2022 The acting director of the US Patent and Trademark Office Andrew Hirshfeld has defended his right to review final Patent Trial and Appeal Board decisions under Arthrex.

article

Fed Circ confirms Hirshfeld’s authority in Arthrex

30 May 2022 The Federal Circuit has ruled that the interim commissioner of the United States Patent and Trademark Office had decision-making powers in the ongoing Arthrex case.

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

Google ‘stole’ tech to become undisputed search leader, claims Nevada tech company

How specialisation transformed Brazil’s patent system

Powell Gilbert co-founder joins US firm's European push

The Eurasian Patent Organization: A growing attraction

Plaintiff's non-compete play 'gives pro-business fans reason to celebrate'

Ocado IP chief: ‘The UPC is of strategic value in settlements’

US urges court to rethink ‘patent bounty’ case between chipmakers

Hirshfeld grants first USPTO director review after Arthrex

More on this story

Editor's picks

Editor's picks

More articles